Categories Analysis, Earnings, Industrials
Paychex Q2 2019 earnings preview: strong cash balance to aid the performance
HR solutions company Paychex (PAYX) is scheduled post its second-quarter results on Wednesday, Dec. 19. Analysts expect the payroll processor to lift its earnings to $0.63 per share on revenue of $857 million.
For the previously reported quarter, Paychex reported better-than-expected results, helped by solid growth in human capital management products. Revenue rose 9% to $862.8 million, beating Wall Street expectations.
As it posted the results back in October, Paychex also posted fiscal 2019 outlook, where it expected management solutions revenue to increase by about 4%. Meanwhile, PEO and insurance services revenues were anticipated to increase about 18-20%.
In November, Paychex displayed the might of its strong cash balance and low debt as it agreed to buy privately-held professional employer organization Oasis Outsourcing Acquisition Corp based in West Palm Beach, Florida.
The addition of Oasis is expected to contribute considerably to Paychex’s revenues in the forthcoming quarters by allowing the company to expand to new markets and offer its HR solutions to a larger number of clients. The stock, which currently trades slightly above the levels seen about twelve months ago, continues to maintain the upward trend. It opened Monday’s session higher.
The addition of Oasis is expected to contribute considerably to Paychex’s revenues in the forthcoming quarters
Paychex CEO Martin Mucci said: “This acquisition will strengthen our PEO growth strategy, gain scale for new products with our insurance carrier partners, provide a new client base to offer Paychex retirement and time and attendance products, and augment our experienced management team. This is a great time for our two companies to come together.”
In October, Credit Suisse raised the stock to outperform from neutral, further highlighting the strength of the company’s payroll service.
Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference, and much more!
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on